perspectives on the treatment of patients with r/r multiple myeloma
Published 2 years ago • 160 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
1:26
mrd in myeloma: the fda perspective
-
8:42
assessing mrd in multiple myeloma
-
1:37
mrd in myeloma
-
1:09
the efficacy & role of iberdomide in r/r multiple myeloma
-
1:57
the role of selinexor in the context of novel immune therapies in r/r multiple myeloma
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
9:25
mgus diagnosis: a step-by-step approach
-
4:04
the future of myeloma treatment and the possibility of cure
-
1:19
al amyloidosis: mrd negativity
-
1:42
immune profiling & mrd negativity of ndmm treated with quadruplet induction autosct: milestone trial
-
1:48
investigating the role of the stromal niche in the development of myeloma
-
7:10
the current state of the art in r/r multiple myeloma: a european perspective
-
1:11
the importance of mrd evaluation in myeloma
-
1:50
molecular characteristics of extramedullary myeloma
-
6:33
mrd as a tool to discontinue therapy in mm?
-
1:53
the future of multiple myeloma treatment
-
7:07
multiple myeloma coverage on vjhemonc!
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
2:17
extended follow-up of the master trial
-
4:40
management of r/r myeloma and mrd assessment
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
3:04
monumental-1 update: talquetamab in r/r multiple myeloma